These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 23649605)
1. In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model. Lynch ME; Brooks D; Mohanan S; Lee MJ; Polamraju P; Dent K; Bonassar LJ; van der Meulen MC; Fischbach C J Bone Miner Res; 2013 Nov; 28(11):2357-67. PubMed ID: 23649605 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis. Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491 [TBL] [Abstract][Full Text] [Related]
3. Mechanical loading attenuates breast cancer-associated bone metastasis in obese mice by regulating the bone marrow microenvironment. Huang M; Liu H; Zhu L; Li X; Li J; Yang S; Liu D; Song X; Yokota H; Zhang P J Cell Physiol; 2021 Sep; 236(9):6391-6406. PubMed ID: 33554336 [TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. Pratap J; Akech J; Wixted JJ; Szabo G; Hussain S; McGee-Lawrence ME; Li X; Bedard K; Dhillon RJ; van Wijnen AJ; Stein JL; Stein GS; Westendorf JJ; Lian JB Mol Cancer Ther; 2010 Dec; 9(12):3210-20. PubMed ID: 21159607 [TBL] [Abstract][Full Text] [Related]
5. Tracking the Progression of Osteolytic and Osteosclerotic Lesions in Mice Using Serial In Vivo μCT: Applications to the Assessment of Bisphosphonate Treatment Efficacy. Campbell GM; Tower RJ; Damm T; Kneissl P; Rambow AC; Schem C; Tiwari S; Glüer CC J Bone Miner Res; 2018 Mar; 33(3):410-418. PubMed ID: 29044710 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. Zinonos I; Luo KW; Labrinidis A; Liapis V; Hay S; Panagopoulos V; Denichilo M; Ko CH; Yue GG; Lau CB; Ingman W; Ponomarev V; Atkins GJ; Findlay DM; Zannettino AC; Evdokiou A Int J Oncol; 2014 Aug; 45(2):532-40. PubMed ID: 24865346 [TBL] [Abstract][Full Text] [Related]
7. A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes. Jones MD; Liu JC; Barthel TK; Hussain S; Lovria E; Cheng D; Schoonmaker JA; Mulay S; Ayers DC; Bouxsein ML; Stein GS; Mukherjee S; Lian JB Clin Cancer Res; 2010 Oct; 16(20):4978-89. PubMed ID: 20843837 [TBL] [Abstract][Full Text] [Related]
8. Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis. Yang S; Liu H; Zhu L; Li X; Liu D; Song X; Yokota H; Zhang P FASEB J; 2019 Oct; 33(10):10742-10752. PubMed ID: 31266364 [TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090 [TBL] [Abstract][Full Text] [Related]
10. Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model. Missbach-Guentner J; Dullin C; Zientkowska M; Domeyer-Missbach M; Kimmina S; Obenauer S; Kauer F; Stühmer W; Grabbe E; Vogel WF; Alves F Neoplasia; 2007 Sep; 9(9):755-65. PubMed ID: 17898871 [TBL] [Abstract][Full Text] [Related]
11. Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites. Abdelaziz DM; Stone LS; Komarova SV Breast Cancer Res Treat; 2015 Aug; 153(1):9-20. PubMed ID: 26208488 [TBL] [Abstract][Full Text] [Related]
12. Sclerostin induced tumor growth, bone metastasis and osteolysis in breast cancer. Zhu M; Liu C; Li S; Zhang S; Yao Q; Song Q Sci Rep; 2017 Sep; 7(1):11399. PubMed ID: 28900298 [TBL] [Abstract][Full Text] [Related]
13. Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo. Chantry AD; Heath D; Mulivor AW; Pearsall S; Baud'huin M; Coulton L; Evans H; Abdul N; Werner ED; Bouxsein ML; Key ML; Seehra J; Arnett TR; Vanderkerken K; Croucher P J Bone Miner Res; 2010 Dec; 25(12):2633-46. PubMed ID: 20533325 [TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion. Virk MS; Alaee F; Petrigliano FA; Sugiyama O; Chatziioannou AF; Stout D; Dougall WC; Lieberman JR Bone; 2011 Mar; 48(3):578-87. PubMed ID: 21073986 [TBL] [Abstract][Full Text] [Related]
16. Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients. Henry MD; Silva MD; Wen S; Siebert E; Solin E; Chandra S; Worland PJ Prostate; 2005 Dec; 65(4):347-54. PubMed ID: 16032708 [TBL] [Abstract][Full Text] [Related]
17. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation. Tester AM; Sharp JA; Dhanesuan N; Waltham M; Thompson EW Clin Exp Metastasis; 2002; 19(5):377-83. PubMed ID: 12198765 [TBL] [Abstract][Full Text] [Related]
18. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902 [TBL] [Abstract][Full Text] [Related]
19. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions. Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283 [TBL] [Abstract][Full Text] [Related]
20. The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis. Subik K; Shu L; Wu C; Liang Q; Hicks D; Boyce B; Schiffhauer L; Chen D; Chen C; Tang P; Xing L Bone; 2012 Apr; 50(4):813-23. PubMed ID: 22266093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]